Madhavan Nallani

Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.

Synpromics Agbiosub Ltd. is a British company that engages in research and experimental development on biotechnology. The private company is based in London, UK.

EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom.

Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers.

APAF Ltd. provides proteomic services. The non-profit company is based in Sydney, Australia.

Ondek Pty Ltd. develops natural immune modulatory products for allergic disorders. It offers ImmBALANCE, a product for allergy indications. The firm develops core ingredient for products that will reduce the allergic response in children, adolescents and adults. The company was founded by Barry Marshall in 2005 and is headquartered in Sydney, Australia.

QUT Creative Enterprise Australia engages in design, fashion, entertainment, photography, music, film and television, digital technology, games and interactive content. It offers coterie, fashion accelerator, CEA business hub, startup fund, creative, and venue hire services. The company was founded in 2008 and is headquartered in Kelvin Grove, Australia.

qutbluebox Pty Ltd. provides business consulting and investment services for start ups. It work together with Queensland University of Technology researchers to assess, develop and protect innovative intellectual property. It services provides support to researchers in the areas of consulting services, continuing education, international projects and contract research and assists with grant administration, collaborative research, ethics, research budgets and data management. The company was founded in 2006 and is headquartered in Kelvin Grove, Australia.

Solvanix Pty Ltd. develops novel therapy for improving stability and reducing the aggregation of fully human antibodies. The company was founded by Daniel Christ in 2014 and is headquartered in Darlinghurst, Australia.

Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013.

Part of Valneva SE, Valneva Canada, Inc. engages in marketing and distribution of vaccines. The company is based in Kirkland, Canada.

Vascular Flow Technologies Ltd. develops vascular devices. It offers Spiral Flow Peripheral Vascular Graft, Spiral Flow AV Access Graft, Spiral Laminar Flow, Power of Spiral Laminar Flow and unique design eliminates graft turbulences. The company was founded by Peter Stonebridge, Brian Howlett, Graeme Houston and John B.C. Dick and headquartered in Dundee, the United Kingdom.

Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom.

Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK

Ambicare Health Ltd. manufactures medical products for skin care. The firm develops and commercializes proprietary, light emitting diode (LED) based devices for the treatment skin conditions and diseases. Its ambulatory lighting products offer solutions incorporating OLED (Organic Light Emitting Diode) and LED (Light Emitting Diode) technologies. The products offer battery operated flexible packaged solutions with high light uniformity. The company was founded by James Ferguson and Ifor Samuel in 2004 and is headquartered in Livingston, the United Kingdom.

Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia.

Founded in 1929, Glaxo Laboratories Ltd. is a pharmaceutical wholesaler that is part of GSK Plc. The company is based in London, UK.

Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom.

QSpine Ltd. designs, manufactures and distributes medical devices in the surgical spine market segment. Its products include Mobi-C, sterispine pedicle screw, sterispine lumber cage and spinetune and shivas cervical cage. The company was founded by Forbes Butterfield and Stuart Hunter Carmichael in 2011 and is headquartered in Corby, the United Kingdom.

Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers.

Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014.